Travere Therapeutics (TVTX) Free Cash Flow Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Travere Therapeutics | 4.34 Bn | 4.26 Bn | 102.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.44% |
| Dec 31, 2025 | 46.40% |
| Sep 30, 2025 | 26.79% |
| Jun 30, 2025 | 22.31% |
| Mar 31, 2025 | -7.52% |
| Dec 31, 2024 | -45.06% |
| Sep 30, 2024 | -24.19% |
| Jun 30, 2024 | -16.17% |
| Mar 31, 2024 | -42.12% |
| Dec 31, 2023 | -86.71% |
| Sep 30, 2023 | -93.99% |
| Jun 30, 2023 | -73.19% |
| Mar 31, 2023 | -46.38% |
| Dec 31, 2022 | -202.29% |
| Sep 30, 2022 | -77.90% |
| Jun 30, 2022 | -55.24% |
| Mar 31, 2022 | -67.19% |
| Dec 31, 2021 | -55.09% |
| Sep 30, 2021 | 47.18% |
| Jun 30, 2021 | 9.89% |
| Mar 31, 2021 | -53.87% |
| Dec 31, 2020 | -29.41% |
| Sep 30, 2020 | 42.63% |
| Jun 30, 2020 | -23.25% |
| Mar 31, 2020 | -34.71% |
| Dec 31, 2019 | 13.67% |
| Sep 30, 2019 | 1.68% |
| Jun 30, 2019 | -10.30% |
| Mar 31, 2019 | -15.52% |
| Dec 31, 2018 | 19.68% |
| Mar 31, 2018 | -26.36% |